Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON25081
NL-OMON25081
Completed
Not Applicable

Haemolysis during extracorporeal CO2 removal; an in vitro study using donated human blood.

niversity Medical Centre0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHaemolysis, extracorporeal CO2 removal, low flow CO2 removal, extracorporeal life support, ELS, COPD, exacerbation, chronic obstructive pulmonary disease, acute lung failure.Hemolyse, extracorporale CO2 verwijdering, extracorporale ondersteuning, exacerbatie, acuut longfalen.

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Haemolysis, extracorporeal CO2 removal, low flow CO2 removal, extracorporeal life support, ELS, COPD, exacerbation, chronic obstructive pulmonary disease, acute lung failure.Hemolyse, extracorporale CO2 verwijdering, extracorporale ondersteuning, exacerbatie, acuut longfalen.
Sponsor
niversity Medical Centre
Enrollment
30
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
niversity Medical Centre

Eligibility Criteria

Inclusion Criteria

  • •Healthy volunteer.
  • •Age and gender not relevant.

Exclusion Criteria

  • •Volunteers known with anaemia or those not feeling well.
  • •Volunteer that has taken part in this study and has donated blood during the past 7 days.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Haemolysis during extracorporeal CO2 removal; an in vitro study using donated human bloodHet betreft geen directe aandoening. Het betreft een in vitro onderzoek gebruik makend van donorbloed. De donoren zijn gezonde vrijwilligers.n.v.t.zie C21
NL-OMON41022Medisch Universitair Ziekenhuis Maastricht33
Completed
Not Applicable
ow-flow extracorporeal CO2 removal in patients with moderate ARDS to enhance lung protective ventilation. Pilot feasibility and safety studyARDSshock lung10024967
NL-OMON43868European Society of Intensive Care Medicine (ESICM)10
Not yet recruiting
Not Applicable
ow-flow extra-corporeal CO2 removal and 4 mL/kg tidal volume vs. 6mL/kg tidal volume to enhance protection from ventilator induced lung injury in acute lung injury: a randomized multi-center trialAcute Respiratory Distress Syndromeacute lung failure10024967
NL-OMON37536Erasmus MC, Universitair Medisch Centrum Rotterdam18
Terminated
Not Applicable
Use of Extracorporeal CO2 Removal in Case of Moderate to Severe ARDS to Apply an Ultraprotective Mechanical Ventilation StrategyAcue Respiratory Distress Syndrome
NCT04556578University Hospital, Montpellier2
Completed
Not Applicable
Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress SyndromeARDSHypercapnic Respiratory FailureAKI
NCT04351906University of Giessen20